# Safety and Efficacy of Etanercept in Patients With Psoriasis

> **NCT02258282** · NA · UNKNOWN · sponsor: **Chengdu PLA General Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Etanercept
- **DRUG:** Control

## Key facts

- **NCT ID:** NCT02258282
- **Lead sponsor:** Chengdu PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-05
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2017-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02258282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02258282, "Safety and Efficacy of Etanercept in Patients With Psoriasis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02258282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*